Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Dose of Varenicline on Post-quitting Urges to Smoke
NCT01206010Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jul 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tobacco dependence comparing Varenicline + Active Tailored Dose with Varenicline + Placebo Tailored Dose (2 arms). Primary endpoint: Rating of urges to smoke. Started Jul 2011; status: completed.
02
Drugs
varenicline
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT01206010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206010.